Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

PFE

Pfizer Inc

Jun 17 • 04:00PM ET

24.00

Dollar change -0.40
Percentage change -1.64	%

Healthcare • Drug Manufacturers - General • USA • NYSE

Peers: BMY MRK SNY AMGN ABBV NVS JNJ GSK LLY AZN

| Held by: VTI VOO SPY IVV VTV XLV VYM VHT COWZ DVY

Scroll to Statements

Index	S&P 500	P/E	17.39	EPS (ttm)	1.38	Insider Own	0.18%	Shs Outstand	5.68B	Perf Week	-1.23%
Market Cap	136.45B	Forward P/E	7.78	EPS next Y	3.09	Insider Trans	0.17%	Shs Float	5.67B	Perf Month	5.12%
Income	7.87B	PEG	-	EPS next Q	0.57	Inst Own	67.07%	Short Float	1.85%	Perf Quarter	-8.78%
Sales	62.46B	P/S	2.18	EPS this Y	-3.50%	Inst Trans	0.76%	Short Ratio	2.00	Perf Half Y	-5.40%
Book/sh	15.89	P/B	1.51	EPS next Y	2.83%	ROA	3.67%	Short Interest	104.99M	Perf Year	-13.20%
Cash/sh	3.05	P/C	7.88	EPS next 5Y	-0.27%	ROE	8.62%	52W Range	20.92 - 31.54	Perf YTD	-9.54%
Dividend Est.	1.71 (7.11%)	P/FCF	12.16	EPS past 5Y	-13.25%	ROIC	5.32%	52W High	-23.91%	Beta	0.54
Dividend TTM	1.70 (7.08%)	Quick Ratio	0.96	Sales past 5Y	9.10%	Gross Margin	66.93%	52W Low	14.75%	ATR (14)	0.49
Dividend Ex-Date	May 09, 2025	Current Ratio	1.26	EPS Y/Y TTM	2770.58%	Oper. Margin	27.53%	RSI (14)	53.71	Volatility	1.38% 1.35%
Employees	81000	Debt/Eq	0.69	Sales Y/Y TTM	13.38%	Profit Margin	12.59%	Recom	2.44	Target Price	28.11
Option/Short	Yes / Yes	LT Debt/Eq	0.64	EPS Q/Q	-5.13%	Payout	119.94%	Rel Volume	0.77	Prev Close	24.40
Sales Surprise	-1.47%	EPS Surprise	38.22%	Sales Q/Q	-7.82%	Earnings	Apr 29 BMO	Avg Volume	52.40M	Price	24.00
SMA20	1.30%	SMA50	3.78%	SMA200	-7.71%	Trades		Volume	40,408,780	Change	-1.64%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-22-25	Initiated	Cantor Fitzgerald	Neutral	$24
Dec-10-24	Resumed	BofA Securities	Neutral	$29
Nov-15-24	Initiated	Wolfe Research	Underperform	$25
Oct-25-24	Resumed	Citigroup	Neutral	$30
Oct-17-24	Initiated	Bernstein	Mkt Perform	$32
Aug-07-24	Upgrade	Daiwa Securities	Neutral → Outperform
Mar-22-24	Downgrade	Argus	Buy → Hold
Feb-23-24	Initiated	Guggenheim	Buy	$36
Jan-04-24	Downgrade	TD Cowen	Outperform → Market Perform	$32
Oct-20-23	Resumed	UBS	Neutral	$36 → $34
Oct-16-23	Upgrade	Jefferies	Hold → Buy	$38 → $39
Jul-17-23	Reiterated	JP Morgan	Neutral	$45 → $41
Jul-14-23	Initiated	HSBC Securities	Buy	$50
Jun-29-23	Downgrade	Credit Suisse	Outperform → Neutral	$47 → $40
May-11-23	Downgrade	Daiwa Securities	Outperform → Neutral	$38
Mar-06-23	Initiated	Jefferies	Hold	$43
Feb-07-23	Upgrade	Daiwa Securities	Neutral → Outperform	$51
Jan-26-23	Downgrade	UBS	Buy → Neutral	$55 → $47
Jan-17-23	Downgrade	Wells Fargo	Overweight → Equal Weight	$54 → $50
Jan-04-23	Downgrade	BofA Securities	Buy → Neutral	$60

Show Previous Ratings

Today 07:00AM	2 Top Stocks to Buy With Less Than $30 (Motley Fool)
Jun-17-25 07:34PM	Analyst Report: Haleon plc (Morningstar Research)
05:16PM	Trump's big beautiful bill: What the pharma industry is watching (Yahoo Finance Video)
02:39PM	Slowing Gardasil Sales Hurt MRK's Top Line: Is Recovery in the Cards? (Zacks)
11:20AM	Cantor Fitzgerald Maintains PFE At Neutral Amid Vaccine Guidance Changes and Regulatory Challenges (Insider Monkey)
11:18AM	Loading…
11:18AM	AMD extends gains, solar stocks plummet, pharma stocks (Yahoo Finance Video)
10:32AM	Trump reportedly threatens pharma ads, disrupting $10B market (Yahoo Finance Video)
10:12AM	RFK Jr. Plans Crackdown on Pharma Ads in Threat to $10 Billion Market (Bloomberg)
09:40AM	Should Value Investors Buy Pfizer (PFE) Stock? (Zacks)
09:02AM	5 Low Price-to-Book Value Stocks That You Can Buy in June (Zacks)
04:49AM	Why I Just Bought More of This Beaten-Down 7%-Yielding Dividend Stock (Motley Fool)
Jun-16-25 11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
11:20AM	EMA Accepts GSK's Filing for Expanded Use of RSV Vaccine Arexvy (Zacks)
09:29AM	4 Value Stocks to Shield Your Portfolio Amid Geopolitical Turmoil (Zacks)
09:06AM	5 Large Drug Stocks That Are Poised to Ride on Sector Recovery (Zacks)
09:00AM	Loading…
09:00AM	Can J&J's Innovative Medicines Unit Sustain Growth Amid Stelara LOE? (Zacks)
Jun-15-25 05:47AM	Goldman Sachs Maintains a Hold Rating on Pfizer (NYSE:PFE), Retains $27 PT (Insider Monkey)
Jun-13-25 12:45PM	Senators to propose ban on drug ads to consumers, WSJ reports (TipRanks)
11:30AM	JPMorgan biotech/pharma analysts hold analyst/industry conference call (TipRanks)
09:15AM	Novartis AG (NVS) Hit a 52 Week High, Can the Run Continue? (Zacks)
Jun-12-25 10:21AM	PFE's New & Acquired Drugs Hold Key to Revenue Growth Amid Headwinds (Zacks)
08:15AM	Novavax's COVID-Flu Combo Shot Shows Strong Immune Response (Zacks)
05:00AM	Create a Portfolio of Passive Income: 3 High-Yielding Dividend Stocks That Pay More Than 5% (Motley Fool)
Jun-11-25 11:27AM	Pfizer CEO Mentioned No Drug Price Commitments by Pfizer Inc. (PFE) (Insider Monkey)
10:57AM	Trump Wants Cheaper Drugs Like Europe Has. How It Works. (Barrons.com)
10:20AM	Trump Trade: RFK Jr. removes members of vaccine-advising CDC panel (TipRanks)
09:40AM	Pfizer says drugmakers met with Trump admin to discuss lowering drug prices (TipRanks)
Jun-10-25 04:10PM	Vaccine Stocks Mixed After RFK Jr. Fires CDC's Entire Vaccine Committee (Investor's Business Daily)
10:50AM	Merck Secures FDA Nod for New RSV Antibody Enflonsia in Infants (Zacks)
10:23AM	Top Cancer Stocks to Supercharge Your 2025 Portfolio (Zacks)
10:19AM	Loading…
10:19AM	BlackRock, Goldman Scale Up Tax Trades in $3 Trillion SMA Boom (Bloomberg)
10:10AM	RFK Jr. removes CDC vaccine panel members: What to know (Yahoo Finance Video)
08:18AM	Why Moderna, Pfizer Stocks Are Shrugging Off RFK Jr.'s Firing of Vaccine Advisors. (Barrons.com)
Jun-09-25 07:12PM	RFK Jr. Fires All 17 Members of CDC's Vaccine Advisory Board (Barrons.com)
06:09PM	Vaccine Stocks Moderna, Pfizer Hit After A Surprise Blow From RFK Jr. (Investor's Business Daily)
12:50PM	Pfizer and other drug companies make 'no commitments' to the White House on lower drug prices (Quartz)
10:18AM	Pfizer Stock Down Almost 11% YTD: Should You Buy the Dip? (Zacks)
09:00AM	Pfizer Inc. (PFE) is Attracting Investor Attention: Here is What You Should Know (Zacks)
08:33AM	No drug price pledges by Pfizer, others in talks with US government, Pfizer CEO says (Reuters)
Jun-08-25 06:35AM	3 Stocks With Mouthwatering Dividends You Can Buy Right Now (Motley Fool)
Jun-07-25 09:00AM	Failed Muni Bond Draws FBI and Sparks Ponzi-Like Fraud Claims (Bloomberg)
06:30AM	Should You Buy Pfizer Stock Right Now? (Motley Fool)
05:59AM	Patents and economies of scale support Pfizer's wide moat (GuruFocus.com)
05:23AM	2 Beaten-Down Dividend Stocks to Buy Now and Hold at Least a Decade (Motley Fool)
Jun-06-25 04:16PM	Challenges pharma companies face in push into US manufacturing (Yahoo Finance Video)
09:40AM	Was Jim Cramer Right About Pfizer Inc. (PFE)? (Insider Monkey)
09:16AM	BMY Collaborates for Oncology Drug: Will This Boost Its Portfolio? (Zacks)
07:00AM	Arvinas Announces Submission of New Drug Application to U.S. FDA for Vepdegestrant for Patients with ESR1-Mutated ER+/HER2- Advanced or Metastatic Breast Cancer (GlobeNewswire)
05:15AM	Zacks.com featured highlights JAKKS Pacific, Green Dot, Signet Jewelers, Gibraltar Industries and Pfizer (Zacks)
04:00AM	With ADCs on the rise, drugmakers embrace a new oncology pillar (Pharma Voice)
01:30AM	Despite Trade War, U.S. Drug Companies Turn to China for Key Cancer Treatments (Barrons.com)
Jun-05-25 12:10PM	5 Bargain Stocks With Low P/S Ratios & High Growth Return Potential (Zacks)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Shot in the Arm (The Wall Street Journal)
09:10AM	Pre-Tariff Pharma Stockpiling Gives Irish Economy a Huge Booster Shot (The Wall Street Journal)
03:34AM	Better High-Yield Dividend Stock to Buy Now: Pfizer vs. Prologis (Motley Fool)
03:06AM	Here Are All 6 Stocks I've Bought Through 5 Months of 2025 (Motley Fool)
Jun-04-25 04:57AM	Zacks.com featured highlights StoneCo, Centene, CVS Health and Pfizer (Zacks)
04:47AM	EC approves Takeda ADC plus chemo for stage IIb Hodgkins lymphoma (Pharmaceutical Technology)
Jun-03-25 12:16PM	Moderna Secures FDA Nod for Next-Gen COVID-19 Vaccine mNexspike (Zacks)
12:11PM	Bristol Myers Collaborates With BNTX for Oncology Candidate (Zacks)
10:24AM	Top 4 Value Stocks to Buy as Trade Tensions Still Cloud H2 Outlook (Zacks)
07:59AM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
03:06AM	3 Safe Ultra-High-Yield Dividend Stocks -- Sporting an Average Yield of 11.35% -- That Make for No-Brainer Buys in June (Motley Fool)
Jun-02-25 09:00PM	How Moderna Went From Pandemic Hero to Vaccine Victim (The Wall Street Journal)
01:38PM	Why BioNTech Stock Soared Today (Motley Fool)
11:39AM	Bristol Myers Joins Pharma's Hottest Horserace in $11.1B Deal With BioNTech (Barrons.com)
10:00AM	Pfizer Invites Public to Listen to Webcast of Pfizer Discussion at Healthcare Conference (Business Wire)
09:38AM	Gilead Reports Positive Data From Trodelvy, Keytruda Combo Study (Zacks)
08:46AM	Bristol Myers makes $11 billion deal with BioNTech to join the cancer-drug race (MarketWatch)
08:07AM	Bristol to Pay BioNTech Up to $11.1 Billion in Cancer Deal (Bloomberg)
Jun-01-25 11:34PM	Branded Pharmaceuticals Stocks Q1 Results: Benchmarking Pfizer (NYSE:PFE) (StockStory)
09:15AM	Terrible News for Pfizer Stock Investors (Motley Fool)
May-31-25 08:00AM	Arvinas and Pfizer's Vepdegestrant Significantly Improves Progression-Free Survival for Patients with ESR1-Mutant, ER+/HER2- Advanced Breast Cancer (GlobeNewswire)
04:00AM	Full Arvinas, Pfizer data confirm potential, limits of Protac drug in breast cancer (BioPharma Dive)
May-30-25 03:10PM	Pfizer Reports Survival Gains In Colorectal Cancer Study, Combo Therapy Cuts Death Risk By Over 50% (Benzinga)
11:42AM	ASCO25: Pfizers Braftovi combo boasts 47% drop in disease progression in mCRC (Pharmaceutical Technology)
08:00AM	Pfizers BRAFTOVI Combination Regimen Cuts the Risk of Death in Half for Patients with BRAF V600E-Mutant Metastatic Colorectal Cancer (Business Wire)
May-29-25 11:29PM	Pfizer Inc. (PFE) Ends Acepodia Partnership Amid Depo-Provera Legal Woes (Insider Monkey)
11:40AM	PFE or LLY: Which Is the Better Value Stock Right Now? (Zacks)
11:30AM	Pfizer (PFE) Down 5% Since Last Earnings Report: Can It Rebound? (Zacks)
10:29AM	Pfizer and Arvinas gamble to shift breast cancer treatment paradigm (Clinical Trials Arena)
09:40AM	Are Investors Undervaluing Pfizer (PFE) Right Now? (Zacks)
09:18AM	Bristol Myers Loses 20.7% in 3 Months: Buy, Sell or Hold the Stock? (Zacks)
09:05AM	5 Valuable Price-to-Book Stocks to Strengthen Your Portfolio (Zacks)
May-28-25 08:00AM	Hearing Against Pfizer Set For 30 May In Contraceptive 'Depo-Provera' Multidistrict Litigation Overseen By Levin Papantonio (Business Wire)
May-27-25 10:00AM	Is Pfizer Stock a Buy After This $1.25 Billion Investment? (Motley Fool)
09:00AM	Pfizer Inc. (PFE) Is a Trending Stock: Facts to Know Before Betting on It (Zacks)
05:21AM	Pfizer headquarters conversion project in Manhattan gets $720m loan (World Construction Network)
May-26-25 09:41AM	MRNA Seeks FDA Nod for Updated COVID-19 Vaccine (Zacks)
09:38AM	Roche Gets CHMP Nod for Itovebi Combo in the EU for Breast Cancer (Zacks)
09:16AM	GILD Announces Positive Data on Trodelvy in First-Line Breast Cancer (Zacks)
May-24-25 03:00PM	Junkiest Junk Is Offering a Warning Sign for Debt (Bloomberg)
08:45AM	Down 63%, Should You Buy the Dip on Pfizer? (Motley Fool)
05:00AM	Charting the Global Economy: Long-Term Bond Yields Soar Around the World (Bloomberg)
04:51AM	1 Ultra-High-Yield Dividend Stock Down 57% to Buy Hand Over Fist (Motley Fool)
04:11AM	U.S. Pharmaceutical Imports Might Soon Face Tariffs: 3 Stocks That Could Tumble as a Result (Motley Fool)
May-23-25 05:10PM	Astellas Pharma and Pfizers Xtandi shows long-term survival in prostate cancer (TipRanks)
04:09PM	Regeneron Initial Data on Multiple Myeloma Drug Encouraging (Zacks)
04:02PM	Roche Gets FDA Nod for Label Expansion of Susvimo for Third Indication (Zacks)
03:21PM	Pfizer's 7.5% Dividend: Income Haven or House of Cards? (MarketBeat)

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. The company was founded by Charles Pfizer Sr. and Charles Erhart in 1849 and is headquartered in New York, NY.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Dolsten Mikael	Former Officer	May 23 '25	Proposed Sale	23.09	59,781	1,380,632		May 23 10:54 AM
Dolsten Mikael	Former Officer	May 05 '25	Proposed Sale	23.87	55,000	1,312,736		May 05 04:45 PM
DAMICO JENNIFER B.	SVP & Controller	Mar 04 '25	Sale	25.93	2,500	64,825	11,850	Mar 06 01:57 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 27 '25	Option Exercise	31.31	22,416	701,845	31,063	Mar 03 05:39 PM
SUSMAN SALLY	Executive Vice President	Feb 27 '25	Option Exercise	31.31	85,182	2,667,048	250,866	Mar 03 05:38 PM
SAHNI PAYAL	Executive Vice President	Feb 27 '25	Option Exercise	31.31	19,054	596,581	44,242	Mar 03 05:38 PM
McDermott Michael	Executive Vice President	Feb 27 '25	Option Exercise	31.31	48,419	1,515,999	122,413	Mar 03 05:37 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 27 '25	Option Exercise	31.31	156,914	4,912,977	309,790	Mar 03 05:37 PM
Fonseca Lidia	Executive Vice President	Feb 27 '25	Option Exercise	31.31	72,629	2,274,014	111,534	Mar 03 05:36 PM
BOURLA ALBERT	Chairman & CEO	Feb 27 '25	Option Exercise	31.31	582,823	18,248,188	931,744	Mar 03 05:36 PM
McDermott Michael	Executive Vice President	Feb 22 '25	Option Exercise	30.17	11,125	335,641	87,636	Feb 25 07:38 PM
DAMICO JENNIFER B.	SVP & Controller	Feb 22 '25	Option Exercise	30.17	8,741	263,716	17,602	Feb 25 07:38 PM
BOURLA ALBERT	Chairman & CEO	Feb 22 '25	Option Exercise	30.17	238,399	7,192,498	570,436	Feb 25 07:06 PM
LANKLER DOUGLAS M	Executive Vice President	Feb 22 '25	Option Exercise	30.17	85,824	2,589,310	232,775	Feb 25 07:05 PM
SAHNI PAYAL	Executive Vice President	Feb 22 '25	Option Exercise	30.17	12,714	383,581	37,099	Feb 25 07:04 PM
SUSMAN SALLY	Executive Vice President	Feb 22 '25	Option Exercise	30.17	63,573	1,917,997	225,184	Feb 25 07:02 PM
BOSHOFF CHRISTOFFEL	President, R&D	Feb 22 '25	Option Exercise	30.17	8,741	263,716	159,085	Feb 25 06:58 PM
BLAYLOCK RONALD E	Director	Feb 13 '25	Buy	25.65	19,457	499,072	27,707	Feb 14 05:16 PM
Gottlieb Scott	Director	Oct 30 '24	Buy	28.24	1,000	28,240	10,000	Oct 31 04:06 PM
DAMICO JENNIFER B.	SVP & Controller	Aug 13 '24	Sale	28.66	5,154	147,714	8,582	Aug 14 03:47 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PFE

Pfizer Inc

Upgrade your FINVIZ experience